Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionRoman Butler Fullerton & Co
Latest Disclosed Ownership2,339 shares
Latest Disclosed Value $ 331,125
Roman Butler Fullerton & Co reports 1.34% increase in ownership of GILD / Gilead Sciences, Inc.

On April 30, 2026 - Roman Butler Fullerton & Co filed a 13F-HR form disclosing ownership of 2,339 shares of Gilead Sciences, Inc. (CH:GILD) valued at $331,125 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 2,308 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,339 31 1.34 331 9.60 0.0911
2026-01-26 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,308 -762 -24.82 303 -16.80 0.0794
2025-11-06 2025-09-30 13F GILEAD SCIENCES COM 375558103 3,070 -2,594 -45.80 364 -44.83 0.0976
2025-07-30 2025-06-30 13F GILEAD SCIENCES COM 375558103 5,664 -120 -2.07 658 7.69 0.1940
2025-04-21 2025-03-31 13F GILEAD SCIENCES COM 375558103 5,784 2,654 84.79 611 105.03 0.2373
2025-01-30 2024-12-31 13F GILEAD SCIENCES COM 375558103 3,130 3,130 298 0.0947
2024-10-29 2024-09-30 13F GILEAD SCIENCES COM 375558103 0 -3,445 -100.00 0 -100.00
2024-07-15 2024-06-30 13F GILEAD SCIENCES COM 375558103 3,445 81 2.41 237 4.89 0.0766
2024-04-29 2024-03-31 13F GILEAD SCIENCES COM 375558103 3,364 -735 -17.93 225 -30.77 0.0844
2024-01-31 2023-12-31 13F GILEAD SCIENCES COM 375558103 4,099 -240 -5.53 326 -3.27 0.1268
2023-10-18 2023-09-30 13F GILEAD SCIENCES COM 375558103 4,339 -20 -0.46 337 -2.33 0.1590
2023-07-25 2023-06-30 13F GILEAD SCIENCES COM 375558103 4,359 -88 -1.98 344 -9.47 0.1579
2023-04-27 2023-03-31 13F GILEAD SCIENCES COM 375558103 4,447 -96 -2.11 381 -2.06 0.1893
2023-01-23 2022-12-31 13F GILEAD SCIENCES COM 375558103 4,543 196 4.51 388 36.14 0.2007
2022-10-17 2022-09-30 13F GILEAD SCIENCES COM 375558103 4,347 -95 -2.14 285 2.52 0.1812
2022-07-26 2022-06-30 13F GILEAD SCIENCES COM 375558103 4,442 103 2.37 278 7.75 0.1544
2022-05-05 2022-03-31 13F GILEAD SCIENCES COM 375558103 4,339 -762 -14.94 258 -30.27 0.1194
2022-01-24 2021-12-31 13F GILEAD SCIENCES COM 375558103 5,101 -40 -0.78 370 9.14 0.1635
2021-11-10 2021-09-30 13F GILEAD SCIENCES COM 375558103 5,141 -41 -0.79 339 -5.04 0.1582
2021-07-29 2021-06-30 13F GILEAD SCIENCES COM 375558103 5,182 -79 -1.50 357 3.18 0.1737
2021-04-22 2021-03-31 13F GILEAD SCIENCES COM 375558103 5,261 -41 -0.77 346 11.97 0.1731
2021-02-01 2020-12-31 13F GILEAD SCIENCES COM 375558103 5,302 39 0.74 309 -7.21 0.1824
2020-10-15 2020-09-30 13F GILEAD SCIENCES COM 375558103 5,263 -158 -2.91 333 -20.14 0.2178
2020-07-28 2020-06-30 13F GILEAD SCIENCES COM 375558103 5,421 5,421 417 0.2974
2020-04-13 2020-03-31 13F GILEAD SCIENCES COM 375558103 0 -8,221 -100.00 0 -100.00
2020-01-27 2019-12-31 13F GILEAD SCIENCES COM 375558103 8,221 -790 -8.77 534 -6.48 0.3523
2019-10-15 2019-09-30 13F GILEAD SCIENCES COM 375558103 9,011 -377 -4.02 571 -9.94 0.3948
2019-07-22 2019-06-30 13F GILEAD SCIENCES COM 375558103 9,388 -750 -7.40 634 -3.79 0.4260
2019-04-24 2019-03-31 13F GILEAD SCIENCES COM 375558103 10,138 -1,013 -9.08 659 -13.18 0.4607
2019-02-04 2018-12-31 13F GILEAD SCIENCES COM 375558103 11,151 11,151 759 0.6453
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.